Use of electronic personal health records to identify patients at risk for aspirin-induced gastrointestinal bleeding

Consultant Pharmacist

Volumn 28, Issue 5, 2013, Pages 313-318

  Jackson, Anita N ^a   Kogut, Stephen ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Aspirin; Electronic personal health records; Gastrointestinal bleeding; Medication related problems; Pharmacist

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADULT; AGED; ARTICLE; DRUG INDUCED DISEASE; ELECTRONIC MEDICAL RECORD; ELECTRONIC PERSONAL HEALTH RECORD; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHARMACIST; PRESCRIPTION; RISK FACTOR; SELF CARE; SELF REPORT; UPPER GASTROINTESTINAL BLEEDING;

AGED; AGED, 80 AND OVER; ASPIRIN; ELECTRONIC HEALTH RECORDS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PLATELET AGGREGATION INHIBITORS; PROFESSIONAL ROLE; RISK FACTORS; SELF REPORT;

EID: 84878812231     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2013.313     Document Type: Article

References (16)

1. Glossary of Selected Health IT Terms. Washington, DC: Office of the National Coordinator for Health information Teachnology; 2011. Available at http://healthit.hhs.gov/portal/server.pt/community/health-it-hhs-gov-glossary/ 1256. Accessed December 27, 2011.
2. Markle Foundation. The Personal Health Working Group. Final report July 1, 2003. Available at http://www.policyarchive.org/collections/markle/ index?section=5&id=15473. Accessed July 19, 2011.
3. Undem T. Consumers and Health Information Technology: A National Survey. April 2010. Available at http://www.chcf.org/publications/2010/04/consumers-and- health-information-technology-anational-survey. Accessed June 7, 2011.
4. Krist AH, Woolf SH. A vision for patient-centered health information systems. JAMA 2011;35:300-1.
5. Huang ES, Strate LL, Ho WW et al. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med 2011;124:426-33.
6. Bhatt DL, Scheiman J, Abraham NS et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Circulation 2008;118:1894-909.
7. Garcia Rodriguez LA, Lin KJ, Hernandez-Diaz S et al. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation 2011;123:1108-15.
8. Stewart AL, Lynch KJ. Identifying discrepancies in electronic medical records through pharmacist medication reconciliation. J Am Pharm Assoc 2012;52:59-66.
9. Seshasai SRK, Wijesuriya S, Sivakumaran R et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med 2012;172:209-16.
10. Jackson AN, Hume AL. Aspirin for CV prevention - for which patients? J Fam Pract 2011;60:518-23.
11. Kim EH, Stolyar A, Lober WB et al. Challenges to using an electronic personal health record by a low-income elderly population. J Med Internet Res 2009;11:e44.
12. Yachimski PS, Friedman LS. Gastrointestinal bleeding in the elderly. Nat Clin Pract Gastroenterol Hepatol 2008;5:80-93. (Pubitemid 351234278)
13. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long-term use of aspirin: meta-analysis. BMJ 2000;321:1183-7.
14. Serrano P, Lanas A, Arroyo MT et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002;16:1945-53.
15. Hsiao FY, Tsai YW, Huang WF et al. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Clin Ther 2009;31:2038-47.
16. Saini SD, Schoenfeld P, Fendrick AM et al. Cost-effectiveness of proton pump inhibitor co-therapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention. Arch Intern Med 2008;168:1684-90.